首页> 美国卫生研究院文献>Experimental and Therapeutic Medicine >MicroRNA-382 inhibits cancer cell growth and metastasis in NSCLC via targeting LMO3
【2h】

MicroRNA-382 inhibits cancer cell growth and metastasis in NSCLC via targeting LMO3

机译:MicroRNA-382通过靶向LMO3抑制NSCLC中癌细胞的生长和转移

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Recent studies have revealed a pivotal role of microRNAs (miRs) in regulating the initiation and development of multiple types of cancer. In the present study, it was discovered that miR-382 may be an important tumor suppressor in non-small cell lung cancer (NSCLC). It was demonstrated that miR-382 expression was downregulated in tumor tissues from patients with NSCLC compared with adjacent normal tissues. Furthermore, overexpression of miR-382 suppressed cell proliferation and cell migration of NSCLC cells. In addition, reverse transcription-quantitative polymerase chain reaction and the luciferase reporter assay revealed that LIM-only protein 3 (LMO3), an oncogene, acted as a direct target gene of miR-382. Notably, overexpression of miR-382 did not alter cell proliferation or migration in LMO3-silenced A549 cells. Furthermore, analysis of patient tissues indicated an elevation of LMO3 expression in tumor tissues compared with adjacent normal tissues and a negative association between miR-382 and LMO3 mRNA expression levels. Taken together, the present findings indicated that miR-382 inhibited NSCLC cell proliferation and metastasis by targeting LMO3, suggesting a tumor suppressor role of miR-382 in NSCLC.
机译:最近的研究表明,microRNA(miRs)在调节多种癌症的发生和发展中起着关键作用。在本研究中,发现miR-382可能是非小细胞肺癌(NSCLC)中重要的肿瘤抑制因子。已证明与邻近的正常组织相比,NSCLC患者的肿瘤组织中的miR-382表达下调。此外,miR-382的过表达抑制了NSCLC细胞的细胞增殖和细胞迁移。此外,逆转录定量聚合酶链反应和荧光素酶报告基因分析表明,仅LIM蛋白3(LMO3)是一种癌基因,它是miR-382的直接靶基因。值得注意的是,miR-382的过表达不会改变LMO3沉默的A549细胞的细胞增殖或迁移。此外,对患者组织的分析表明,与邻近的正常组织相比,肿瘤组织中的LMO3表达升高,而miR-382与LMO3 mRNA表达水平之间呈负相关。综上所述,本研究结果表明miR-382通过靶向LMO3抑制NSCLC细胞增殖和转移,提示miR-382在NSCLC中具有肿瘤抑制作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号